On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Episodes
73 episodes
American Diabetes Association on the Wrong Side of Compounded GLP-1 Meds
https://diabetes.org/newsroom/press-releases/american-diabetes-association-announces-statement-compounded-incretin
•
21:02
Like Ozempic, But You Only Take It Once! Fractyl Health CEO Dr. Harith Rajagopalan
CEO and Co-Founder of Fractyl Health ($GUTS) Dr. Harith Rajagopalan joins On The Pen to discuss their #Revita and #Rejuva programs for type 2 diabetes and obestityhttps://www.fractyl.com/
•
38:56
Retatrutide Cagrisema & Obesity Medicine Future With Dr. Michael Albert
Dr Michael Albert and Dave Knapp discuss the current events in GLP-1 medications as well as the horizon of future anti obesity medicine.
•
1:26:48
Medicare to Cover Zepbound and Wegovy?
https://www.onthepen.com/post/medicare-medicaide-to-cover-zepbound-here-s-why-it-s-not-as-simple-as-it-sounds
•
20:41
Compound Tirzepatide Future + @FitFlavorFun : OTP EPS 91
Ali G. from @FitFlavorFun joins Dave to talk all things GLP-1!
•
1:23:02
On The Pen: The Weekly Dose 11.19.24
https://www.nature.com/articles/d41586-024-03614-9https://www.wsj.com/health/pharma/weight-loss-drugs-employer-healthcare-coverage-12817e4fhttps://www.reuters.com/bu...
•
20:17
CNN Special: Is Ozempic For You? With Dr. Gupta OTP REVIEW
Dave reviews the CNN special with Dr Sanjay Gupta on GLP-1 medications.
•
18:42
Dr Spencer Nadolsky: Docs Who Lift Pod | OTP Eps 90
Dr Spencer Nadolski of the “Docs Who Life” podcast joins Dave to recap obesity week, and to deep dive into Dave’s ongoing struggle with obesity and type 2 diabetes.
•
1:36:59
Novo Nordisk's War on Compound Semaglutide, Maritide Has Some Negative News
In this episode of On The Pen: The Weekly Dose, host Dave Knapp dives into the latest updates in obesity medicine, with insightful takes on current treatment breakthroughs, new medication approvals, and tips on navigating healthcare op...
•
27:42
Viking Therapeutics and AstraZeneca Steal The Show at Obesity Week!
Semaglutide News: https://www.onthepen.com/post/select-trial-update-semaglutide-s-cardiovascular-benefits-and-psychiatric-safety-profile-highlighteViking Therapeutics News:https://www.onthepen.com/post/vk2735-vikingtideAstra...
•
30:41
Lilly Earnings Call Analysis: Why Zepbound Missed Earnings
Dave brings his analysis of the Q3 Eli Lilly earnings call, and how it relates to the future of access to obesity medicine. Also there is an important clarification on the Zepbound savings card that you should not miss.
•
38:25
New Zepbound Savings Card, GLP-1 Accessibility Landscape Evolves
Lilly Releases 2025 Zepobound Savings Card Details:https://www.onthepen.com/post/breaking-zepbound-savings-card-2025-released-what-yo...
•
16:59
Inside the Legal Battle for Compound Tirzepatide: What You Need to Know from Industry Insider Scott Brunner!
An article on the news broken by Mr Brunner on compound Tirzepatide: https://www.onthepen.com/post/compound-tirzepatidea4pc.org
•
38:07
Tirzepatide Lawsuits Filed By Lilly, Catalent Reframing Novo Merger
Lilly Lawsuits: https://www.onthepen.com/post/eli-lilly-zepbound-tirzepatide-lawsuitsCatalent Merger: https://www.businesswire.com/news/home/20241020996199/en/Catalent-Issues-Open-Letter-to-Customers-Regarding-Pending-Acquisition-by-Nov...
•
30:17
Compounded Zepbound Legal Battle Landscape: Legal Expert Weighs In
OTP legal correspondent Lee (@LeeFitsIn) joins Dave to discuss where we stand in the legal battle over compounded versions of Zepbound and Mounjaro. (Apologies for audio, the interview was a TikTok live recording). 🛒Amazon Affiliat...
•
1:16:41
Compounded Zepbound Uncertainty + Leveraging GLP-1 To Improve Labor Shortages
Zepbound Compound News:https://www.onthepen.com/zepbound-newsNew type two diabetes treatment:https://www.upi.com/Health_News/2024/10/14/ozempic-intestinal-therapy-eliminate-insulin-Type-2-diabetics/6911728911126/Using GL...
•
18:45
Heartbreaking Zepbound Story | OTP Eps 85
OTP community member Megan a.k.a. Spoonie Megumi shares her heartbreaking journey to Zepbound.Two of my favorite products on this journey (affiliate links below)Renpho Bodyweight Analyzer: https://I...
•
1:27:37
Tirzepatide Lawsuits + Ozempic Patent Victory
Semaglutide Patent: https://www.fiercepharma.com/pharma/novos-patent-litigation-settlement-mylan-could-pave-way-cheaper-ozempic-genericsOutsourcing Facilities Association Lawsuit: https://www.reuters.com/legal/compounding-group-sues-fda...
•
19:42
Megadosing Zepbound and Mounjaro With Dr. Daniel Rosen
Dr. Daniel Rosen talks candidly about his approach to slow responders to GLP medications in his bariatric clinic.
•
1:28:39
Ozempic and Zepbound Supply Impacted by Port Worker Strike!
PORT WORKER STRIKE: https://www.cnbc.com/2024/10/01/port-strike-blockbuster-weight-loss-drug-supply-trade-shutdown.htmlZEPBOUND FOR NON-OBESE: https://www.ft.com/content/b2da2ca6-822e-4d42-bee4-e500522531e7WEIGHT WATCHERS CEO OU...
•
19:20
Amy Kane @AmyInHalf Discusses Dramatic Mounjaro Transformation
Amy Kane (@AmyInHalf) joins to talk about her rise to GLP stardom, and Dave discusses all the relevant news of the week!Aired live at 9pm central, Thursday 9/26/24.Watch The Video Version: GLP-1 Clapback Queen Amy Kane | OTP...
•
59:15
On The Pen: The Weekly Dose 9.24.24
Metsera MET-097: https://www.fiercebiotech.com/biotech/metseras-long-acting-glp-1-shot-linked-75-weight-loss-36-days-data-sparseBiomed Pharma NA-931: https://www.biomedind.com/NA-931.htmlWatch the Novo Nordisk Hearings:
•
25:18
Eli Lilly Compound Tirzepatide Letters + Retatrutide Trial Guest!
We discuss the Eli Lilly letters that are going out to users of compound Tirzepatide. Mimi from the #Retatrutide trial joins! Plus our new segment maintenance minute with Korrie, where Korrie discusses all things weight maintenance!📺 Watch ...
•
1:16:09
BCBS Demanding Refunds From Ozempic Prescribers? | The Weekly Dose 9.17.24
Discord: https://discord.gg/QUEp5DBeNew New Facebook Group: https://www.facebook.com/share/g/Ab2ApGdaqRQj1T6c/Medicare and Ozempichttps://qz.com/ozempic-price-cut-medicare-negotiations-1851650680BCBS Demanding Payme...
•
16:53